Home
Lynx1 Capital Management, 10% Owner: Passage BIO PASG Buy · Filed 06/29
Trade details
- Type
- Insider buy
- Amount
- $206,226.6
- Shares · price
- 50,055 sh · $4.12 a share
- Held after
- 673,759 sh
- Stock
- Passage BIO PASG
- Trade date
- 26/06/25
- Filed
- 26/06/29
- Days to filing
- 4 days
First buy since 2023
- Insiders buying this week
- 2 insiders
- Holding change
- +8.0%
Passage BIO trades, last 26 weeks
What else happened in Passage BIO around then
Filed or reported within 30 days of the trade day · 05/26~07/25Lynx1 Capital Management's recent trades
- Lynx1 Capital Management
BuyKorro Bio
BuyKorro Bio
KRRO
$5,512
520 sh
$5,512
Filed 04/02
Traded 03/31
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$72.1K
80,069 sh
$72.1K
Filed 25/12/23
Traded 25/12/19
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$68K
75,500 sh
$68K
Filed 25/12/23
Traded 25/12/22
- Lynx1 Capital Management
BuyTScan Therapeutics
BuyTScan Therapeutics
TCRX
$5,609
6,232 sh
$5,609
Filed 25/12/23
Traded 25/12/23
- Lynx1 Capital Management
BuyCullinan Therapeutics
BuyCullinan Therapeutics
CGEM
$1.4M
165,667 sh
$1.4M
Filed 25/10/30
Traded 25/10/28
